BrainJuicer Group PLC
14 September 2007
BrainJuicer Group PLC
('BrainJuicer' or 'the Company')
Directors Dealings
BrainJuicer Group PLC, (AIM: BJU), a leading international online market
research agency, was today informed that Ken Ford, Non-Executive Chairman, has
today purchased 10,000 Ordinary Shares of 1p each in the Company ('Ordinary
Shares') at a price of 202p per Ordinary Share. Following this transaction, Mr.
Ford is interested in 10,000 Ordinary Shares, representing 0.08% of the total
issued share capital of the Company.
- Ends -
For further information, please contact:
BrainJuicer plc
John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000
www.brainjuicer.com
Landsbanki Securities (UK) Limited
Fred Walsh / Simon Brown Tel: +44 (0)20 7426 9000
www.landsbanki.co.uk
Media enquiries:
Abchurch Communications
Heather Salmond / Joanne Shears Tel: +44 (0) 20 7398 7700
joanne.shears@abchurch-group.com www.abchurch-group.com
Notes to Editors:
BrainJuicer carries out quantitative online research using innovative, bespoke
software to produce insightful market research for large, multinational
companies, including 10 of the world's top 50 companies (FT 500 September 2006).
BrainJuicer operates in a growing sector of the US$25bn global research market,
namely quantitative online research. BrainJuicer's main competitors are large
traditional market research providers who have dominated the market for off-line
market research, such as AC Nielsen, Millward Brown, Research International and
Taylor Nelson Sofres.
Whilst the largest traditional research companies have developed their own
online capability, BrainJuicer has a number of key attributes which have
contributed to it achieving rapid growth and winning contracts with prestigious
clients, including:
• Research platform that delivers greater diagnostic insight. BrainJuicer has
developed tools and award-winning techniques that enable it to provide a greater
level of diagnostic insight into quantitative market research. These techniques
enable clients to enhance their understanding of consumer preference and help
them make decisions on the best way to develop their products and services.
• Speed. BrainJuicer's automated research techniques enable it to conduct
complicated studies very quickly. BrainJuicer's rapid deployment and results
production, even on multi-country studies, provide clients with a speed to
market advantage in the development of new products and services.
• A scaleable online-only business model. Unlike the traditional research
companies who maintain both on and offline data collection capabilities,
BrainJuicer is able to focus on operating a scaleable online-only business
model.
To date the Group has conducted projects in over 50 countries and more than 30
languages and has established offices in the UK, the Netherlands and the US.
The Group's revenues come from full service market research work, and from its
online Juicy Brains Panel in the UK.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.